Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

569 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study).
Tzoumpa S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, El Aarbaoui T, Dereure O, Quereux G, Faiz S, de Vicq de Cumptich M, Ram-Wolff C, Janela-Lapert R, Guenova E, Lheure C, Le Corre Y, Adamski H, Blanchard M, Bonnet N, Amatore F, Grange F, Troin L, Bagot M, Beylot-Barry M. Tzoumpa S, et al. Among authors: blanchard m. Br J Dermatol. 2024 Apr 25:ljae153. doi: 10.1093/bjd/ljae153. Online ahead of print. Br J Dermatol. 2024. PMID: 38660811 No abstract available.
What is new about primary cutaneous B cell lymphomas.
Blanchard M, Hoetzenecker W, Blanchard G, Guenova E. Blanchard M, et al. Among authors: blanchard g. Ital J Dermatol Venerol. 2023 Jun;158(3):205-216. doi: 10.23736/S2784-8671.23.07572-2. Ital J Dermatol Venerol. 2023. PMID: 37278499 Free article. Review.
Vorinostat for treatment-refractory bullous pemphigoid.
Blanchard G, Solly F, Basset V, Fontao L, Blanchard M, Guenova E. Blanchard G, et al. Among authors: blanchard m. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1218-e1220. doi: 10.1111/jdv.19209. Epub 2023 Jun 8. J Eur Acad Dermatol Venereol. 2023. PMID: 37191129 No abstract available.
Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
Blanchard M, Morren MA, Busschots AM, Hauben E, Alberti-Violetti S, Berti E, Avallone G, Tavoletti G, Panzone M, Quaglino P, Colonna C, Melchers RC, Vermeer MH, Gniadecki R, Mitteldorf C, Gosmann J, Stadler R, Jonak C, Oren-Shabtai M, Hodak E, Friedland R, Gordon E, Geskin LJ, Scarisbrick JJ, Mayo Martínez F, Noguera Morel L, Pehr K, Amarov B, Faouzi M, Nicolay JP, Kempf W, Blanchard G, Guenova E. Blanchard M, et al. Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093/bjd/ljae150. Online ahead of print. Br J Dermatol. 2024. PMID: 38595050
[Tinea capitis: new insights into an old disease].
Blanchard M, Norrenberg S, Monod M, Morren MA, Guenova E. Blanchard M, et al. Rev Med Suisse. 2023 Mar 29;19(820):618-623. doi: 10.53738/REVMED.2023.19.820.618. Rev Med Suisse. 2023. PMID: 36988169 French.
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.
Ríos-Tamayo R, Lecumberri R, Cibeira MT, González-Calle V, Alonso R, Domingo-González A, Landete E, Encinas C, Iñigo B, Blanchard MJ, Alejo E, Krsnik I, Gómez-Bueno M, Garcia-Pavia P, Segovia-Cubero J, Rosiñol L, Lahuerta JJ, Martínez-López J, Bladé J. Ríos-Tamayo R, et al. Among authors: blanchard mj. Cancers (Basel). 2024 Apr 26;16(9):1689. doi: 10.3390/cancers16091689. Cancers (Basel). 2024. PMID: 38730641 Free PMC article.
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.
Medina-Herrera A, Vazquez I, Cuenca I, Rosa-Rosa JM, Ariceta B, Jimenez C, Fernandez-Mercado M, Larrayoz MJ, Gutierrez NC, Fernandez-Guijarro M, Gonzalez-Calle V, Rodriguez-Otero P, Oriol A, Rosiñol L, Alegre A, Escalante F, De La Rubia J, Teruel AI, De Arriba F, Hernandez MT, Lopez-Jimenez J, Ocio EM, Puig N, Paiva B, Lahuerta JJ, Bladé J, San Miguel JF, Mateos MV, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R; GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group. Medina-Herrera A, et al. Blood Cancer J. 2024 Apr 29;14(1):74. doi: 10.1038/s41408-024-01053-3. Blood Cancer J. 2024. PMID: 38684670 Free PMC article. Clinical Trial.
569 results